amyloidosis
- مهر- 1397 -1 مهر
First RNAi Drug Approved in Europe After 20 Years of Research
First RNAi Drug Approved in Europe After 20 Years of Research The first ever RNA interference(i) drug, used to treat polyneuropathy in patients with hereditary…
-- بیشتر بخوانید -- - آبان- 1396 -8 آبان
درمان اختلالات نادر با داروهای RNA
RNA Interference Drug Excels in Clinical Trials to Treat Rare Disorder Alnylam Pharmaceuticals is reporting positive results from a clinical trial using patisiran—an RNA interference…
-- بیشتر بخوانید --
